Boya Xinhe Overview
- Year Founded
-
2014
- Status
-
Private
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
Boya Xinhe General Information
Description
Developer of anti-infective, diabetes, and cardiovascular drugs for medical use. The company is committed to the research, development, production and sales of anti-infective, diabetes and cardiovascular drugs, its products cover four dosage forms: tablets, capsules, granules, and active pharmaceutical ingredients (APIs).
Contact Information
Corporate Office
- No. 333, Gaoxin 6th Road
- Fuzhou High-tech Industrial Development Zone
- Fuzhou, Jiangxi 344000
- China
Corporate Office
- No. 333, Gaoxin 6th Road
- Fuzhou High-tech Industrial Development Zone
- Fuzhou, Jiangxi 344000
- China
Boya Xinhe Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Boya Xinhe Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Boya Xinhe FAQs
-
When was Boya Xinhe founded?
Boya Xinhe was founded in 2014.
-
Where is Boya Xinhe headquartered?
Boya Xinhe is headquartered in Fuzhou, China.
-
What industry is Boya Xinhe in?
Boya Xinhe’s primary industry is Drug Discovery.
-
Is Boya Xinhe a private or public company?
Boya Xinhe is a Private company.
-
What is the current valuation of Boya Xinhe?
The current valuation of Boya Xinhe is .
-
What is Boya Xinhe’s current revenue?
The current revenue for Boya Xinhe is .
-
Who are Boya Xinhe’s investors?
Fuzhou Xinkaiyuan Fund has invested in Boya Xinhe.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process